Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
WuXi AppTec SHSE:603259 |
306,54 B | 29,04% | 6/6 | 16,77% | 47,30% | 33,27% | UP |
|
WuXi Biologics (Cayman) SEHK:2269 |
144,73 B | 31,93% | 6/6 | 12,45% | 67,35% | 29,30% | UP |
|
Pharmaron Beijing SZSE:300759 |
50,97 B | 20,79% | 5/6 | 31,44% | 70,52% | 30,56% | UP |
|
Hangzhou Tigermed Consulting SZSE:300347 |
45,19 B | 10,66% | 4/6 | 21,16% | 55,34% | 21,59% | DOWN |
|
XtalPi Holdings SEHK:2228 |
41,31 B | 465,97% | 1/2 | -31,66% | -43,79% | 12,50% | UP |
|
Genscript Biotech SEHK:1548 |
27,04 B | 13,53% | 3/6 | 58,57% | 20,07% | 41,83% | DOWN |
|
Beijing Hotgen Biotech SHSE:688068 |
11,19 B | 0,00% | 4/5 | 0,00% | 0,00% | -100,00% | DOWN |
|
HitGen SHSE:688222 |
10,33 B | 27,40% | 6/6 | 44,14% | 56,23% | 5,18% | UP |
|
PharmaBlock Sciences (Nanjing) SZSE:300725 |
8,64 B | 13,56% | 3/5 | 267,34% | 16,58% | -100,00% | DOWN |
|
Shanghai Medicilon SHSE:688202 |
8,24 B | 0,00% | 1/5 | 0,00% | 19,39% | -100,00% | UP |
|
Shanghai Runda Medical Technology SHSE:603108 |
7,46 B | -14,23% | 2/5 | 20,49% | -18,64% | 61,81% | DOWN |
|
Beijing Sun-Novo Pharmaceutical Research SHSE:688621 |
7,23 B | 0,00% | 0/0 | 240,75% | -15,98% | -100,00% | UP |
|
Novogene SHSE:688315 |
5,70 B | -1,36% | 4/6 | 127,16% | 20,09% | 13,14% | DOWN |
|
R&G PharmaStudies SZSE:301333 |
6,27 B | 0,34% | 0/0 | 9,78% | -17,93% | 27,86% | UP |
|
Hangzhou Bio-Sincerity Pharma-Tech SZSE:301096 |
5,71 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
PharmaResources (Shanghai) SZSE:301230 |
5,53 B | 0,00% | 0/0 | 194,48% | -60,05% | -100,00% | UP |
|
SMO ClinPlus CO.,LTD. SZSE:301257 |
4,82 B | 0,00% | 0/0 | 0,00% | 0,00% | -48,62% | UP |
|
Boji Medical Technology SZSE:300404 |
3,91 B | 0,00% | 0/0 | 102,31% | 16,29% | -100,00% | UP |
|
Shanghai Obio Technology (Group) Corp. SHSE:688238 |
4,41 B | 0,00% | 0/0 | 35,30% | 0,00% | 65,86% | DOWN |
|
Viva Biotech Holdings SEHK:1873 |
4,16 B | -13,50% | 2/4 | 0,00% | -554,87% | 42,13% | UP |
